Back to company

LICA PHARMACEUTICALS ApS: Financial statements 2016

CVR: 25332520

LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 737,979 and a net result of DKK 327,524 compared with DKK -2,255,485 the year before. That is an increase of 136.5% compared with the year before. Equity amounted to DKK 11,982,987. The solvency ratio was 99.1%.

Gross Profit
737,979 kr.
Profit/Loss
327,524 kr.
Equity
11,982,987 kr.
Total Assets
12,096,231 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-738 t.328 t.12 mio.-
2015-312 t.-2.3 mio.11.7 mio.-
2014-269 t.3.9 mio.13.9 mio.-
2013-341 t.783 t.10 mio.-
2012468 t.296 t.953 t.9.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is LICA PHARMACEUTICALS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

LICA PHARMACEUTICALS ApS: The 2015 annual report is outMay 31, 2016

LICA PHARMACEUTICALS ApS has published its annual report for 2015. Gross profit came to DKK 312,007, and the net result was DKK -2,255,485.

About LICA PHARMACEUTICALS ApS

LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.